Ashley Preston

Ashley Preston has a diverse background in global regulatory affairs, quality assurance, and operational excellence. Ashley has held key leadership positions at various pharmaceutical companies such as Syros Pharmaceuticals, H3 Biomedicine, EMD Serono, and Merck Pte Ltd, Singapore. Ashley's roles have included building and leading regulatory and quality teams, strategizing global regulatory approaches, and engaging with regulatory agencies. Throughout their career, they have demonstrated a strong emphasis on compliance, risk mitigation, and driving successful product development across different regions.

Ashley Preston completed a BSc (Honours) in Pharmacology at Monash University from 1996 to 1999. Ashley then pursued a PhD in Pharmacology at RMIT University from 2000 to 2003. Ashley also obtained Cert. IV in Workplace Training & Assessment at David Kay Training & Development Services Pty Ltd in 2003. In 2008, they earned a Regulatory Affairs Certification (RAC) in US Regulatory Affairs from the Regulatory Affairs Professionals Society (RAPS).